Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin, Susan Swindells, Keikawus Arasteh, Miguel Górgolas Hernández-Mora, Vadim Pokrovsky, Pierre Marie Girard, Shinichi Oka, Jaime F. Andrade-Villanueva, Gary J. Richmond, Axel Baumgarten, Mar Masiá, Gulam Latiff, Sandy Griffith, Conn M. Harrington, Krischan J. Hudson, Marty St Clair, Christine L. Talarico, Parul PatelAmy Cutrell, Veerle Van Eygen, Ronald D'Amico, Joseph M. Mrus, Sterling Wu, Susan L. Ford, Ken Chow, Jeremy Roberts, Angela Wills, Nicola Walters, Simon Vanveggel, Rodica Van Solingen-Ristea, Herta Crauwels, Kimberly Y. Smith, William R. Spreen, David A. Margolis

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences